Document Detail


How I treat HIV-associated lymphoma.
MedLine Citation:
PMID:  22337719     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Over the past 10 years, significant progress has been made in understanding HIV-associated lymphomas and improving the prognosis of these diseases. With the advent of combination antiretroviral therapy and the development of novel therapeutic strategies, most patients with HIV-associated lymphomas are cured. The outcome for the majority of patients with HIV-associated diffuse large B-cell lymphoma and Burkitt lymphoma in particular, is excellent, with recent studies supporting the role of rituximab in these diseases. Indeed, in the combination antiretroviral therapy era, the curability of many patients with HIV-associated lymphoma is similar to their HIV-negative counterparts. New treatment frontiers need to focus on improving the outcome for patients with advanced immune suppression and for those with adverse tumor biology, such as the activated B-cell type of diffuse large B-cell lymphoma and the virally driven lymphomas. Future clinical trials need to investigate novel targeted agents alone and in combination with chemotherapy.
Authors:
Kieron Dunleavy; Wyndham H Wilson
Related Documents :
22298959 - The current economic burden of cirrhosis.
22854709 - A role for mucosal il-22 production and th22 cells in hiv-associated mucosal immunopath...
22536089 - Remission of progressive multifocal leukoencephalopathy following highly active antiret...
21799839 - Levels of spending and resource allocation to hiv programs and services in latin americ...
24122519 - Of baby ducklings and clay pots: method and metaphor in hiv prevention.
22213299 - Circulating transforming growth factor-β and epidermal growth factor receptor as relate...
20029819 - Occult hepatitis b infection in patients infected with hiv: report of two cases of hepa...
2528479 - Mathematical model of cd4+ lymphocyte depletion in hiv infection.
24974649 - Disseminated cryptococcosis in an hiv-seronegative pregnant woman with transient t-lymp...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Intramural; Review     Date:  2012-02-15
Journal Detail:
Title:  Blood     Volume:  119     ISSN:  1528-0020     ISO Abbreviation:  Blood     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-04-11     Completed Date:  2012-06-19     Revised Date:  2013-06-26    
Medline Journal Info:
Nlm Unique ID:  7603509     Medline TA:  Blood     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3245-55     Citation Subset:  AIM; IM    
Affiliation:
Center for Cancer Research, National Cancer Institute, 9000 Rockville Pike, Bethesda, MD 20892, USA. dunleavk@mail.nih.gov
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / administration & dosage,  therapeutic use
Gene Expression Profiling
HIV Infections / complications*
Humans
Lymphoma / diagnosis,  drug therapy*,  etiology*
Recurrence
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antineoplastic Agents
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The role of gender and weight on rituximab clearance and serum elimination half life in elderly pati...
Next Document:  The embryonic origins of erythropoiesis in mammals.